Thonburi Healthcare Group PCL (BKK:THG) Research & Development: ฿0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:THG Thonburi Healthcare Group PCL BKK:THG
69 GF Score
Price ฿7.45
GF Value ฿10.26
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Thonburi Healthcare Group PCL Research & Development?

Thonburi Healthcare Group PCL BKK:THG +0.68% 69 Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus rates BKK:THG with a GF Score™ of 69/100 and a GF Value™ of ฿10.26 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Thonburi Healthcare Group PCL's Research & Development for the three months ended in Mar. 2026 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0 Mil.

Thonburi Healthcare Group PCL  (BKK:THG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Thonburi Healthcare Group PCL Research & Development Related Terms

Thonburi Healthcare Group PCL Research & Development Historical Data

* Premium members only.

The historical data trend for Thonburi Healthcare Group PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thonburi Healthcare Group PCL Research & Development Chart

Thonburi Healthcare Group PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Thonburi Healthcare Group PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:THG
69GF Score
Thonburi Healthcare Group PCL BKK:THG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thonburi Healthcare Group PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0 Mil mean?
Thonburi Healthcare Group PCL (BKK:THG) has a Research & Development of ฿0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Thonburi Healthcare Group PCL and its competitors.
Is Thonburi Healthcare Group PCL's Research & Development too high?
Thonburi Healthcare Group PCL's current Research & Development is ฿0 Mil. Overall, Thonburi Healthcare Group PCL has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thonburi Healthcare Group PCL's Research & Development compare to HCA and THC?
Thonburi Healthcare Group PCL's Research & Development of ฿0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Thonburi Healthcare Group PCL and its competitors. Thonburi Healthcare Group PCL's current Research & Development is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thonburi Healthcare Group PCL stock overvalued right now?
Based on GuruFocus' analysis, Thonburi Healthcare Group PCL (BKK:THG) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿10.26, compared to a current price of ฿7.45 — trading 27.4% below its estimated fair value. The current Research & Development is ฿0 Mil. Thonburi Healthcare Group PCL's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Thonburi Healthcare Group PCL (BKK:THG), the current Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thonburi Healthcare Group PCL (BKK:THG) Overvalued in 2026?

Based on GuruFocus' analysis, Thonburi Healthcare Group PCL stock appears to be undervalued. The current stock price of ฿7.45 is trading 27.4% below its estimated GF Value™ of ฿10.26. GuruFocus considers Thonburi Healthcare Group PCL to be Modestly Undervalued.

Key valuation signals for BKK:THG:

  • Research & Development: ฿0 Mil
  • GF Value™: ฿10.26 vs. price of ฿7.45 (27.4% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the BKK:THG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thonburi Healthcare Group PCL Business Description

Address 34/1, Issaraphap Road, Banchanglor, Bangkoknoi, Bangkok, THA, 10700
Thonburi Healthcare Group PCL provides medical and hospital management services. It operates private hospitals in Thailand, both in Bangkok and other parts of the country, through direct management, affiliated firms as well as joint ventures. The group's business operations involve six segments: hospital operations; hospital management; healthcare solution provider; development and sales of hospital operation software and property development and holding. It drives majority of its revenue from the hospital operations. The Group's business operations are in the same geographic area which is in Thailand and Singapore.
69GF Score

Get the complete analysis for BKK:THG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿7.45
Price
฿10.26
GF Value